These results indicate that SHCBP1 can promote MCF-7 cell proliferation when CXCL2 is expressed at low levels, which validates our hypothesis that SHCBP1 promotes the development of cancer by inhibiting the inflammation of tumor cells. Here, CXCL2 is linked to neoplasm.